AngioDynamics
ANGO

AngioDynamics (ANGO) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Canaccord GenuityMaintainedBuy$20.00Oct 9, 2026
Canaccord GenuityMaintainedBuy$20.00 from $16.00Jul 15, 2026
HC Wainwright & Co.MaintainedBuy$19.00 from $16.00Jul 15, 2026
Canaccord GenuityMaintainedBuy$16.00 from $18.00Apr 6, 2026
Freedom BrokerInitiated CoverageBuy$16.00Apr 6, 2026
Canaccord GenuityMaintainedBuy$18.00 from $17.00Oct 3, 2025
Canaccord GenuityMaintainedBuy$17.00 from $15.00Jul 16, 2025
HC Wainwright & Co.MaintainedBuy$16.00Jul 16, 2025
Lake StreetInitiated CoverageBuy$24.00Jul 16, 2025
HC Wainwright & Co.MaintainedBuy$16.00 from $15.00Apr 7, 2025
HC Wainwright & Co.MaintainedBuy$15.00 from $14.00Jan 10, 2025
HC Wainwright & Co.MaintainedBuy$14.00Dec 10, 2024
Canaccord GenuityMaintainedBuy$12.00 from $13.00Oct 4, 2024
HC Wainwright & Co.MaintainedBuy$14.00Oct 4, 2024
HC Wainwright & Co.MaintainedBuy$14.00Sep 20, 2024
HC Wainwright & Co.MaintainedBuy$14.00Jul 17, 2024
Canaccord GenuityMaintainedBuy$13.00 from $18.00Jul 17, 2024
HC Wainwright & Co.MaintainedBuy$14.00May 22, 2024
OppenheimerUpgradedPerform → Outperform$12.00Apr 5, 2024
Raymond JamesMaintainedOutperform$10.00 from $12.00Jan 9, 2024

Frequently asked questions

  • What is the latest analyst rating on ANGO?

    On Oct 9, 2026, Canaccord Genuity maintained AngioDynamics at Buy with a price target of $20.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.